NIH

Dear Research Advocate, Tomorrow, our 45th U.S. President will be inaugurated. The challenge and opportunity that President Trump - and all our elected representatives - face is to ensure that the next four years deliver better health, safety and prosperity. I hope President Trump’s inaugural address signals that his Administration will leverage research and innovation to meet our nation’s normative and strategic objectives. With NIH, CDC, AHRQ and FDA under the purview of the Department of Health and Human Services, the new Secretary will influence the nature and pace of medical progress, the capability of our public health infrastructure, and other critical science-relevant variables in...
New leadership in the White House means new leadership in key government positions such as those at the National Institutes of Health (NIH), which houses the Transdisciplinary Collaborative Centers (TCC) for Health Disparities Research Program. TCC supports academic, community, and government coalitions that research social determinants and analyze various health- or non-health-related policies that affect health disparities. Social determinants, such as education, income, and community conditions — which are often tied to race and ethnicity — play a significant role in why certain communities experience higher rates of infant mortality , diabetes , stroke , obesity , and breast cancer...
Dear Research Advocate, On Tuesday, I had the great honor of attending the bill signing for the 21st Century Cures Act (21stCC). It was particularly meaningful that this bill crossed the finish line during Vice President Biden’s tenure. His determination to deliver other families from the cancer tragedy experienced by his own lent a special strength to our collective efforts over a protracted period of congressional debate. If we continue to channel the Vice President’s level of commitment and determination, we can ensure that achieving faster medical progress remains at the forefront of national priorities. As you know (but it never hurts to reaffirm), it is important, but not sufficient,...
Tweet Follow @ResearchAmerica Six science-savvy teams comprised of researchers from around the globe are currently in the running for a grand prize of $230,000 to develop new big data methods for advancing biomedical research. The two-phased Open Science Prize contest was made possible through a collaboration between the National Institutes of Health (NIH) , the Wellcome Trust and the Howard Hughes Medical Institute . During the first phase, the teams received prize money to help create tools or services that could be used to tackle important issues in biomedicine and improve health. They designed prototypes to address subjects such as neuroimaging, rare diseases, mental and neurological...
Dear Research Advocate, As we prepare to celebrate Thanksgiving, it is fitting to thank our public health workforce for their tireless efforts on our behalf every day of the year. Monday marked the official Public Health Thank You Day (PHTYD), but it is ongoing. This year’s effort has been extraordinary, with more than 50 organizations partnering with us to get the word out. For the first time since we launched PHTYD in 2005, Congress officially joined the effort. As I mentioned last week, the co-chairs of the House Public Health Caucus introduced a resolution supporting PHTYD. Online, more than 1,000 organizations and individuals participated, including federal officials from HHS and DOD,...
A new report prepared by leading scientists, thought leaders and policy experts, A Vision and Pathway for NIH , includes recommendations for the new Administration to further advance the nation’s leading biomedical research and health agency-- the National Institutes of Health (NIH). The goal is to better align agency organization and policies with present and future strategies for achieving the highest impact in research and training, and improving health outcomes. The report, written by an ad hoc working group, led by Research!America board member Keith Yamamoto, Ph.D., Vice Chancellor for Science Policy and Strategy; Director, UCSF Precision Medicine; Vice Dean for Research, School of...
Dear Research Advocate: A very close election has entered the history books, in the process laying bare the profound divisions that will challenge all our elected representatives as they seek to unify and heal the nation. We have been deluged with questions about the impact of a Trump Administration on science. A useful primer is his answers to the ScienceDebate.org questionnaire that we and several other groups worked together to create. For example, President-elect Trump says this: “...the federal government should encourage innovation in the areas of space exploration and investment in research and development across the broad landscape of academia.” He also says this: “Though there are...
What, in y our view, are the major challenges facing our nation’s research enterprise? Biomedical research is the driving force behind decades of advances that have improved the health of people in every corner of America—including the lives of those affected by breast cancer. With a robust and sustained investment in biomedical research, the possibilities would be endless. The National Institutes of Health (NIH) and its National Cancer Institute (NCI) have played a role in every major cancer prevention, detection and treatment advance in breast cancer for decades. Within the NIH, the NCI is the principal agency for cancer research and training. The NCI has funded numerous major breast...
U.S. investments in medical and health research and development (R&D) grew by 13.3% over a three year period (2013 – 2015), according to Research!America’s new investment report . However, medical and health R&D represents a small fraction of total spending on health. Currently, the U.S. spends less than 5 cents of every health dollar on R&D to prevent, treat, and cure disease. More than half of Americans (56%) say that is not enough, a recent public opinion survey shows. Industry, including pharmaceutical, medical technolo­gy, biotechnology and health IT companies, invests more in R&D than other sectors. In 2015, industry invested 64.7% of total spending, followed by the...
Founded in 1977, the American Pain Society (APS) is a multidisciplinary organization of basic and clinical scientists, practicing clinicians, policy analysts and others who conduct pain research, treat pain and advocate for individuals with pain. The mission of APS is to advance pain-related research, education, treatment and professional practice. In 2010, after a decade of APS advocacy efforts to address pain as a national issue, the National Institutes of Health (NIH) contracted with the Institute of Medicine (IOM) to undertake a study and make recommendations “to increase the recognition of pain as a significant public health problem in the United States.” According to their landmark...

Pages

Sidebar Quote

Without research, there is no hope.
The Honorable Paul G. Rogers